Physicians’ Exposure to Promotional Tools in Indian Pharmaceutical Industry

Vinita Srivastava


An investigation is described of the perceptions of physicians concerning the association between physicians’ demographics and the frequency of exposure of promotional tools by the pharmaceutical marketers to the physicians. Some practical implications and guidelines are offered by the results to pharmaceutical marketers, with reference to the association of frequency of exposure to promotional tools and physicians’ demographics and the appropriate emphasis that should be placed on them. The relationship between the frequency of exposure to promotional tools and certain categorical variables is investigated. Some strategic implications for marketing of pharmaceutical products are identified, as are areas for further research.


Promotional tools, Pharmaceutical industry, Demographics.

Full Text:



Al-Hamdi, Yahya A, Hassali et al. Impact of pharmaceutical promotion on healthcare professional’s practices and behavior: Views from general practitioners, medicine dispensers and medical representatives in Yemen. Journal of Medical Marketing Nov 2012; 12(4): 240-46. 2. Ram B, Bhardwaj P, Chen Y. Offering pharmaceutical samples: The role of physician learning and patient payment ability. Marketing Science May/Jun 2013; 32(3): 522-27. 3. Backer EL, Lebsackh JA, Van Tonder RJ et al. The value of pharmaceutical representative visits and medication samples in community-based family practices. Journal of Family Practice 2000; 49: 81116. 4. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Family Medicine 2009; 34(10): 729-31. 5. Chew LD, O’Young TS, Hazlet TK et al. A physician survey of the effect of drug sample availability on physicians’ behavior. Journal of General Internal Medicine 2000; 15: 478-83. 6. Daly E. Advertising impact: Using the power of promotional gifts. American Salesman 1993; 38(10): 16-21. 7. Friedman M. The case for new sampling channels. Medical Marketing and Media 1995; 30: 64-68. 8. Gibb F. To give or not to give? Sales & Marketing Management Sep 1994; 146(9): 136-39. 9. Gold R. States battling high drug costs appeal to doctors. Wall Street Journal, Aug 22, 2001; B1. 10. Hensley S. Generic drugs sampled freely in aetna test. Wall Street Journal, Oct 12, 2005; B1. 11. Jain S, Saxena K. Lifestyle and general medicines: A study of promotional-mix strategies in India. Journal of Medical Marketing May 2011; 11(2): 119-26. 12. Joseph K, Mantrala M. A model of the role of free drug samples in physicians’ prescription decisions. Marketing Letters Jan 2009; 20(1): 15-29. 13. Liebman M. Rethinking sampling strategies. Medical Marketing & Media Jun 1997; 32: 36-43. 14. Masood I, Ibrahim MIM, Hassali MAA et al. Evaluation of pharmaceutical industry - Sponsored educational events attended by physicians in

Srivastava V J. Adv. Res. Pharm. Sci. Pharmacol. Interv. 2016; 1(1&2)

Pakistan. Journal of Medical Marketing Jan 2012; 12(1): 22-29. 15. Candis M. The real drug pushers. Newsmagazine (Alberta Edn.), 2001; 28(6): 38-42. 16. Miller RK, Washington K. Promotional spending. Healthcare Business Market Research Handbook. Richard K. Miller & Associates, 2013: 395, 396-98. 17. Alf N. Promotional products are more than just party favors. Long Island Business News 1998; 45(52): 12-25. 18. Parker RS, Pettijohn CE. Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. Journal of Business Ethics 2003; 48: 279-90.

Parker RS, Pettijohn CE. Pharmaceutical drug marketing strategies and tactics: A comparative analysis of attitudes held by pharmaceutical representatives and physicians. Health Marketing Quarterly 2005; 22(4): 27-43. 20. Rabin RC. Free drug samples? Bad idea, some say. New York Times, May 1, 2009. 21. Scott AB, Culley EJ, O’Donnell J. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization. Journal of Managed Care Pharmacy 2008; 13: 412-19. 22. Ubel PA, Jepson C, Asch D. Misperceptions about βblockers and diuretics: A national survey of primary care physicians. Journal of General Internal Medicine 2003; 18: 977-83.


  • There are currently no refbacks.

Comments on this article

View all comments

Copyright (c) 2016